
Employers and members can cut GLP-1 weight-loss costs with carve-outs, split payments, and transparent, updated price guides.
Eric Levin is the CEO and cofounder of Scripta.

Employers and members can cut GLP-1 weight-loss costs with carve-outs, split payments, and transparent, updated price guides.

Scripta allows consumers to compare prescription prices, coupons, and insurance options in one place, helping patients and employers find affordable meds and smarter choices.

Employers use carve-outs and cash-pay channels to reduce GLP-1 costs, while Scripta’s Navigator helps members compare prices and find support.

New GLP-1 pills challenge injections as competition, and discussions of possible Medicare coverage could push prices down.

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding.

Oral GLP-1 costs, insurance gaps, and formulary switches reshape drug pricing and access—learn how to navigate coverage.

Oral Wegovy shifts GLP-1 obesity costs: insurance may match injectables, while cash-pay and pharmacy platforms unlock lower prices and aid programs.